Additive Implants

Executive Summary

Additive Implants is a San Diego-based medical device company specializing in 3D-printed spinal implants. Its flagship product, the SureMAX®-SA Cervical Standalone System, is designed for anterior cervical discectomy and fusion (ACDF) procedures. The system offers a wide range of implant sizes and comprehensive instrumentation to accommodate varied patient anatomies and surgeon preferences, aiming to improve surgical outcomes and reduce operative complexity. By leveraging additive manufacturing, Additive Implants can produce porous, bone-like structures that promote osseointegration and potentially enhance fusion rates compared to traditional implants. The company operates in the competitive spine implant market, but its focus on standalone cervical cages addresses a growing demand for less invasive, efficient solutions. While still private and with limited public financial data, Additive Implants appears well-positioned to capture market share through product differentiation and physician education. Near-term growth will depend on regulatory clearances, clinical adoption, and potential partnerships. With a robust product portfolio and a clear clinical need, Additive Implants represents an emerging player in the spinal device space, though execution risk remains moderate given the competitive landscape and capital requirements for commercialization.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for expanded SureMAX-SA sizes or next-gen implant80% success
• Q4 2026First clinical publication or multi-center study results demonstrating improved fusion rates60% success
• Q2 2027Distribution partnership with a major spine device company50% success